XERS Xeris Biopharma Inc Gross Profit Rate

Corporate emblem and logo of Xeris Biopharma Holdings, Inc. (XERS)

Reliable injection delivery via temperature control ensures therapy readiness, and the base chart on GURU.Markets contains the gross profit percentage, where the latest parameter is 84.40. The Xeris Biopharma (XERS) model is based on alliances with biotech laboratories to create new formulas, while the company relies on standard environmental regulations for waste disposal and energy conservation.

Xeris Biopharma (XERS): Gross Margin from 07/04/2022 to 11/20/2026

Financial and market metric breakdowns for Xeris Biopharma Holdings, Inc. (XERS)

Basic company analysis:Xeris Biopharma Holdings (XERS)
Brand item of Xeris Biopharma Holdings

Gross margin measures production efficiency by determining the portion of revenue remaining after covering direct costs of goods sold. The trend in gross margin allows investors to assess the pricing power of Xeris Biopharma (XERS) in the sale of specialized injection systems for patients with endocrine pathologies, whose expenses are covered by insurance payments.